Scholarlink

Background <p>Shoulder preservation surgery encompasses various joint-sparing procedures aimed at delaying arthroplasty in patients with glenohumeral osteoarthritis (OA). This systematic review synthesises and discusses the evidence on shoulder joint-preservation surgeries for the management of glenohumeral arthritis in adults.</p> Methods <p>This systematic review was conducted following the PRISMA 2020 guidelines and the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions. A comprehensive search of PubMed, Web of Science, and Embase was conducted in June 2025 to identify clinical studies evaluating shoulder joint-preservation surgeries for the management of glenohumeral arthritis in adults. Only studies reporting a minimum follow-up of six months were considered.</p> Results <p>Data from nine studies (333 patients, 335 shoulders) were analysed. The mean age ranged from 41.7 to 57.5&#xa0;years, and 28.8% (96 of 333 patients) were women. The length of the follow-up ranged from 6.0 to 123.7&#xa0;months. The reported surgical interventions primarily involved arthroscopic debridement procedures, often combined with capsular release or subacromial decompression, as well as microfracture with or without biological augmentation and glenoid resurfacing using dermal allografts. The complication rate was 2% (6 of 246 patients), and the infection rate was 0.5% (1 of 199 patients). 22.4% (71 of 317) of patients underwent surgical revision. 19.6% (62 of 317) of patients progressed to total shoulder arthroplasty (TSA), with a reported mean time to conversion of 8.0 to 56.4&#xa0;months.</p> Conclusion <p>Shoulder joint preservation surgeries may alleviate symptoms of glenohumeral OA in adults. Nonetheless, available evidence is constrained by heterogeneity in study design, limited patient numbers, and the absence of comparative data. High-quality prospective studies are needed to refine patient selection criteria and establish evidence-based treatment recommendations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Shoulder joint preservation surgeries in adults

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月21日

查看全文
  • Filippo Migliorini,
  • Luise Schäfer,
  • Virginia Masoni,
  • Fabrizio Rivera,
  • Francesco Cuozzo,
  • Nicola Maffulli

摘要

Background

Shoulder preservation surgery encompasses various joint-sparing procedures aimed at delaying arthroplasty in patients with glenohumeral osteoarthritis (OA). This systematic review synthesises and discusses the evidence on shoulder joint-preservation surgeries for the management of glenohumeral arthritis in adults.

Methods

This systematic review was conducted following the PRISMA 2020 guidelines and the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions. A comprehensive search of PubMed, Web of Science, and Embase was conducted in June 2025 to identify clinical studies evaluating shoulder joint-preservation surgeries for the management of glenohumeral arthritis in adults. Only studies reporting a minimum follow-up of six months were considered.

Results

Data from nine studies (333 patients, 335 shoulders) were analysed. The mean age ranged from 41.7 to 57.5 years, and 28.8% (96 of 333 patients) were women. The length of the follow-up ranged from 6.0 to 123.7 months. The reported surgical interventions primarily involved arthroscopic debridement procedures, often combined with capsular release or subacromial decompression, as well as microfracture with or without biological augmentation and glenoid resurfacing using dermal allografts. The complication rate was 2% (6 of 246 patients), and the infection rate was 0.5% (1 of 199 patients). 22.4% (71 of 317) of patients underwent surgical revision. 19.6% (62 of 317) of patients progressed to total shoulder arthroplasty (TSA), with a reported mean time to conversion of 8.0 to 56.4 months.

Conclusion

Shoulder joint preservation surgeries may alleviate symptoms of glenohumeral OA in adults. Nonetheless, available evidence is constrained by heterogeneity in study design, limited patient numbers, and the absence of comparative data. High-quality prospective studies are needed to refine patient selection criteria and establish evidence-based treatment recommendations.